QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was 22.3%, against 4.9% the year before. The highest annual figure on record is 28.0% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22.3% | +17.4 |
| FY2024 | Dec 31, 2024 | 4.9% | −15.9 |
| FY2023 | Dec 31, 2023 | 20.9% | −4.0 |
| FY2022 | Dec 31, 2022 | 24.8% | −3.2 |
| FY2021 | Dec 31, 2021 | 28.0% | +7.3 |
| FY2020 | Dec 31, 2020 | 20.7% | +22.4 |
| FY2019 | Dec 31, 2019 | -1.7% | −19.5 |
| FY2018 | Dec 31, 2018 | 17.8% | +6.9 |
| FY2017 | Dec 31, 2017 | 10.8% | +3.4 |
| FY2016 | Dec 31, 2016 | 7.4% | −6.6 |
| FY2015 | Dec 31, 2015 | 14.0% | +2.0 |
| FY2014 | Dec 31, 2014 | 12.0% | +7.2 |
| FY2013 | Dec 31, 2013 | 4.9% | −8.7 |
| FY2012 | Dec 31, 2012 | 13.5% | +5.0 |
| FY2011 | Dec 31, 2011 | 8.5% | −8.8 |
| FY2010 | Dec 31, 2010 | 17.3% | −0.5 |
| FY2009 | Dec 31, 2009 | 17.8% | +1.5 |
| FY2008 | Dec 31, 2008 | 16.3% | – |
See a number that looks wrong?